Curaleaf Acquires EMMAC Life Sciences

Curaleaf Holdings Acquires Northern Green Canada

March 19, 2024

Pharmaceuticals

Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.

Curaleaf Holdings Acquires Minority Stake in Curaleaf International

July 2, 2025

Consumer Products

Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.

Columbia Care Acquires Green Leaf Medical

December 22, 2020

Healthcare Services

Columbia Care Inc. has signed a definitive agreement to acquire Green Leaf Medical, LLC for approximately $240 million ( $45 million cash and $195 million in Columbia Care common shares). The acquisition expands Columbia Care's cultivation, manufacturing, retail and wholesale footprint across Pennsylvania, Maryland, Ohio and Virginia, and is expected to be immediately accretive to margins and EBITDA pending regulatory approvals.

Curaleaf Acquires Bloom Dispensaries

December 28, 2021

Consumer Products

Curaleaf Holdings, Inc. agreed to acquire Bloom Dispensaries, a vertically integrated single-state cannabis operator in Arizona, in an all-cash transaction valued at approximately US$211 million. The deal adds four retail dispensaries (Phoenix, Tucson, Peoria, Sedona) plus ~63,500 sq. ft. of adjacent cultivation and processing space in north Phoenix; Curaleaf will pay $51 million cash at close and the remainder via three promissory notes, and Bloom generated estimated 2021 revenue of ~$66 million with EBITDA margins above 40%.

Kester Capital Acquires EMAS Pharma (carve-out from Bionical Emas)

December 24, 2024

Healthcare Services

Kester Capital has acquired EMAS Pharma, the clinical development division of Bionical Emas, in a carve-out transaction alongside an incoming executive team led by experienced CRO operators. The deal creates an independent CRO platform that Kester and the management team intend to scale organically and through acquisitions, expanding capabilities and geographic presence in North America and Europe.

PharmaCann Acquires LivWell Enlightened Health

February 28, 2022

Retail

PharmaCann Inc. has completed its previously announced acquisition of LivWell Holdings, Inc., combining the two vertically integrated cannabis operators into a platform with over 50 dispensaries and 10 cultivation/production facilities across eight U.S. states. The transaction expands PharmaCann's presence into Colorado and Michigan; LivWell founder and CEO John Lord will join the PharmaCann board.